Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2012; 18(31): 4118-4126
Published online Aug 21, 2012. doi: 10.3748/wjg.v18.i31.4118
Published online Aug 21, 2012. doi: 10.3748/wjg.v18.i31.4118
ALT | AST | |
Chronic hepatitis C | 20/40 (50) | 16/40 (40) |
NAFLD | 5/15 (33) | 6/15 (40) |
Autoimmune liver disease | 1/3 (33) | 3/3 (100) |
Total | 26/58 (45) | 25/58 (43) |
- Citation: Hokari A, Ishikawa T, Tajiri H, Matsuda T, Ishii O, Matsumoto N, Okuse C, Takahashi H, Kurihara T, Kawahara KI, Maruyama I, Zeniya M. Efficacy of MK615 for the treatment of patients with liver disorders. World J Gastroenterol 2012; 18(31): 4118-4126
- URL: https://www.wjgnet.com/1007-9327/full/v18/i31/4118.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i31.4118